(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 13.94%1.98B | 6.82%8.42B | 10.29%6.38B | -2.51%3.45B | 2.45%1.74B | 14.96%7.89B | 7.94%5.79B | 1.41%3.54B | 23.39%1.7B | -10.32%6.86B |
Operating income | 13.94%1.98B | 6.82%8.42B | 10.29%6.38B | -2.51%3.45B | 2.45%1.74B | 14.96%7.89B | 7.94%5.79B | 1.41%3.54B | 23.39%1.7B | -10.32%6.86B |
Cost of sales | ---- | 3.37%-5.05B | ---- | 4.57%-2.1B | ---- | -25.49%-5.23B | ---- | 4.50%-2.2B | ---- | -3.32%-4.17B |
Operating expenses | -0.23%-1.15B | 3.37%-5.05B | -6.87%-3.91B | 4.57%-2.1B | -15.76%-1.14B | -25.49%-5.23B | -2.56%-3.66B | 4.50%-2.2B | -23.25%-988.6M | -3.32%-4.17B |
Gross profit | 40.34%834.03M | 26.90%3.37B | 16.17%2.48B | 0.89%1.34B | -16.12%594.29M | -1.34%2.66B | 18.62%2.13B | 12.97%1.33B | 23.59%708.54M | -25.53%2.69B |
Selling expenses | 26.36%-5.84M | 5.21%-31.4M | 55.48%-23.61M | 12.55%-15.25M | 37.38%-7.93M | -5.30%-33.13M | -41.40%-53.04M | 31.39%-17.44M | -6.02%-12.67M | 30.13%-31.46M |
Administrative expenses | -8.44%-251.65M | 0.32%-1.3B | 1.04%-899.42M | 11.50%-571.64M | 15.80%-232.06M | 12.67%-1.31B | -13.68%-908.9M | -14.37%-645.92M | -7.01%-275.6M | -23.69%-1.5B |
Research and development expenses | -33.52%-61.32M | ---- | ---- | ---- | ---45.93M | ---- | ---- | ---- | ---- | ---- |
Profit from asset sales | ---- | ---- | -3.97%47.01K | ---- | -97.89%2.78K | ---- | -95.52%48.96K | ---- | --131.85K | ---- |
Revaluation surplus | 258.76%29.93M | ---- | 11.00%-216.7M | ---- | 82.07%-18.86M | ---- | -153.38%-243.48M | ---- | -379.60%-105.15M | ---- |
-Changes in the fair value of other assets | 258.76%29.93M | ---- | 11.00%-216.7M | ---- | 82.07%-18.86M | ---- | -153.38%-243.48M | ---- | -379.60%-105.15M | ---- |
Impairment and provision | -69.87%3.43M | -47.77%-151.06M | -20.20%-84.14M | 41.43%-32.05M | 386.11%11.39M | -28.05%-102.23M | -453.33%-70M | -101.60%-54.73M | -4.10%-3.98M | 74.23%-79.84M |
-Other impairment is provision | -69.87%3.43M | -47.77%-151.06M | -20.20%-84.14M | 41.43%-32.05M | 386.11%11.39M | -28.05%-102.23M | -453.33%-70M | -101.60%-54.73M | -4.10%-3.98M | 74.23%-79.84M |
Operating interest expense | ---- | ---- | ---- | -11.05%-311.24M | ---- | ---- | ---- | 16.22%-280.27M | ---- | 13.09%-607.87M |
Special items of operating profit | -252.68%-18.32M | -351.42%-152.53M | -81.98%45.48M | 286.91%34.37M | -32.45%12M | 131.03%60.67M | 326.64%252.32M | 69.39%-18.39M | -4.55%17.76M | -432.56%-195.49M |
Operating profit | 73.65%468.47M | 35.95%1.73B | 22.32%1.11B | 42.07%448.6M | -1.15%269.78M | 352.77%1.27B | 25.95%909.15M | 88.47%315.76M | 14.56%272.92M | -78.58%281.59M |
Financing cost | 18.14%-92.63M | -13.97%-607.69M | -7.46%-321.39M | ---- | 8.66%-113.15M | ---533.19M | 26.70%-299.08M | ---- | 24.68%-123.88M | ---- |
Share of profits of associates | ---- | 139.48%1M | ---- | -28.21%2.37M | ---- | -10,232.00%-2.53M | ---- | 148.12%3.31M | ---- | -99.87%25K |
Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | -90.41%7K | ---- | 48.32%-261K | ---- | -98.02%73K |
Special items of earning before tax | -3,542.43%-16.91M | ---- | -78.91%-25.8M | ---- | 108.59%491.18K | ---- | -32.67%-14.42M | ---- | -410.08%-5.72M | ---- |
Earning before tax | 128.46%358.93M | 52.40%1.13B | 28.42%764.91M | 41.46%450.98M | 9.62%157.11M | 162.42%739.21M | 96.62%595.64M | 99.05%318.8M | 97.33%143.32M | -78.94%281.68M |
Tax | -66.15%-80.24M | -60.94%-288.11M | -25.41%-226.82M | 21.44%-85.62M | -5.36%-48.29M | -97.48%-179.02M | -60.52%-180.86M | -68.40%-108.98M | -94.47%-45.84M | 11.67%-90.65M |
After-tax profit from continuing operations | 156.11%278.7M | 49.67%838.42M | 29.73%538.09M | 74.13%365.36M | 11.63%108.82M | 193.24%560.19M | 118.00%414.78M | 119.83%209.82M | 98.71%97.49M | -84.53%191.03M |
Earning after tax | 156.11%278.7M | 49.67%838.42M | 29.73%538.09M | 74.13%365.36M | 11.63%108.82M | 193.24%560.19M | 118.00%414.78M | 119.83%209.82M | 98.71%97.49M | -84.53%191.03M |
Minority profit | 466.16%57.32M | -3.95%151.99M | 15.60%172.78M | 10.26%112.5M | -23.35%10.12M | 0.57%158.23M | -3.78%149.46M | 32.04%102.04M | -49.68%13.21M | -13.85%157.34M |
Profit attributable to shareholders | 124.30%221.38M | 70.77%686.43M | 37.69%365.31M | 134.61%252.86M | 17.11%98.7M | 1,092.84%401.95M | 659.78%265.32M | 493.40%107.78M | 269.44%84.28M | -96.80%33.7M |
Basic earnings per share | 133.33%0.07 | 100.00%0.14 | 37.50%0.11 | 33.33%0.04 | 0.00%0.03 | 600.00%0.07 | 700.00%0.08 | 200.00%0.03 | 200.00%0.03 | -96.88%0.01 |
Diluted earnings per share | 100.00%0.14 | 33.33%0.04 | 600.00%0.07 | 200.00%0.03 | -96.88%0.01 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS | CAS (2007) | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data